Welcome to our dedicated page for Organigram Holdings Common Shares news (Ticker: OGI), a resource for investors and traders seeking the latest updates and insights on Organigram Holdings Common Shares stock.
OrganiGram Holdings Inc. (symbol: OGI) is a leading licensed producer of cannabis, based in Atlantic Canada. As part of Canada’s Marihuana for Medical Purposes Regulations (MMPR), OrganiGram specializes in the cultivation of high-quality, organically grown medical marijuana. The company is committed to providing the best possible medicine and service to its clients.
OrganiGram’s primary operations revolve around the production of indoor-grown cannabis for both medical patients and adult recreational users in Canada. The company has built a diverse portfolio of adult-use recreational cannabis brands including Edison, Big Bag o' Buds, SHRED, Monjour, Holy Mountain, and Trailblazer. Recently, Organigram has expanded its brand lineup with the addition of Tremblant Cannabis and the artisanal craft brand, Laurentian.
OrganiGram has garnered recognition for its innovative and high-quality cannabis products. The company places a strong emphasis on research and development to continually improve its cultivation techniques and product offerings. OrganiGram has also established significant partnerships which support its growth and expansion plans.
Financially, OrganiGram has shown resilience and adaptability in a competitive market. The company regularly updates investors and stakeholders with the latest developments and financial results, ensuring transparency and fostering trust.
OrganiGram Holdings Inc. is dedicated to advancing the cannabis industry through sustainable practices and a commitment to quality. For more information or inquiries, visit www.organigram.ca or contact their client services team at 1-855-961-9420.
Organigram has announced a strategic partnership with Greentank Technologies, aiming to enhance its vape market presence. The deal involves an $4 million USD investment, granting Organigram an 18-month exclusivity on new heating technology for 510 vape cartridges in Canada. This collaboration is anticipated to bolster Organigram’s product lineup, focusing on innovative heating methods that eliminate ceramic components, thus improving user experience. CEO Beena Goldenberg emphasized the commitment to innovation in the vape category, which represents approximately 17% of the Canadian market and continues to expand.
Organigram Holdings Inc. has nominated Caroline Ferland to its Board of Directors, increasing the total number of directors to ten. Ms. Ferland, a lawyer with significant international experience, previously served as BAT's Group Head of Business Conduct and Compliance, leading global compliance initiatives. She holds degrees in Economics and Law from notable Canadian universities. Peter Amirault, Board Chair, emphasized her legal and regulatory expertise as a valuable asset for the company.
Organigram operates as a licensed producer of cannabis products in Canada and aims to expand its international reach.
Organigram Holdings Inc. (NASDAQ: OGI) has received notification from Health Canada regarding its Jolts lozenge products, which were improperly classified. Initially launched in August 2021, these products are deemed cannabis extracts by the company. However, Health Canada has classified them as edibles, leading to a pause in production pending resolution. The company can still sell existing inventory until May 31, 2023. Organigram is consulting legal advisors to address the classification issue.
On February 28, 2023, Organigram Holdings announced the results of its annual general and special meeting.
All nine nominees for director positions were elected successfully, receiving significant shareholder support. For instance, Peter Amirault received 98.34% of votes in favor. The complete list of votes highlights a trend of strong backing for the board, with only a small percentage voting against.
Organigram continues to operate as a licensed cannabis producer in Canada, focusing on quality and expanding its brand portfolio.
Investors can follow updates on the company’s profile through SEDAR and EDGAR.
Organigram Holdings Inc. (NASDAQ: OGI) has launched SHRED X Rip-Strip Hash, an innovative cannabis product designed for convenience and flavor. This hash product features ten pre-cut strips in a 2g format, available in the popular Tropic Thunder and new Blueberry Blaster flavors. The SHRED brand, which has gained a significant market share since its introduction in September 2020, aims to attract both new consumers unfamiliar with traditional hash and existing hash users seeking convenience. With a market share of 25.2%, Organigram is a leading licensed producer in the Canadian hash category.
Organigram Holdings Inc. (NASDAQ: OGI) announced it received a Notification from NASDAQ regarding non-compliance with the minimum bid price requirement. For 30 consecutive trading days, the closing bid price of its common shares was below US$1.00, violating NASDAQ Listing Rule 5450(a)(1). The Notification does not affect the current listing status on NASDAQ, and the Company has until July 24, 2023, to regain compliance by closing at or above US$1.00 for 10 consecutive business days. Failure to comply may result in delisting, although the shares remain compliant on the Toronto Stock Exchange.
Organigram Holdings reported a robust Q1 Fiscal 2023, achieving a 43% increase in net revenue to $43.3 million, up from $30.4 million in the previous year. The company also recorded an Adjusted EBITDA of $5.6 million, marking its fourth consecutive quarter of positive earnings. The Adjusted Gross Margin reached a historic 30%, rising from 18% in the same period last year, driven by operational efficiencies and increased sales volume. Organigram maintained its competitive position in the Canadian market and shipped $5.9 million of product internationally.
Organigram Holdings Inc. (NASDAQ: OGI) will report its earnings results for Q1 fiscal 2023, ending November 30, 2022, on January 12, 2023, before market open. A conference call will be held at 8:00 AM Eastern Time on the same day to discuss the results. Participants can register for the call online and will receive access details via email. Organigram is a leading cannabis producer in Canada, focused on high-quality products and expanding its global footprint through various brands and international partnerships.
Flow Beverage Corp. (OTCQX: FLWBF; TSX: FLOW) has appointed Stephen A. Smith and Michael Lines to its Board of Directors. Smith, with a strong background in finance, will chair the Audit Committee, while Lines, founder of Wellness Natural Inc., will chair the Governance, Human Resources & Compensation Committee. Their appointments aim to enhance Flow's strategic transformation and focus on profitable growth in the consumer packaged goods sector. Flow is recognized as one of North America's fastest-growing premium water companies, emphasizing sustainable practices and health-oriented products.
FAQ
What is the current stock price of Organigram Holdings Common Shares (OGI)?
What is the market cap of Organigram Holdings Common Shares (OGI)?
What is OrganiGram Holdings Inc.?
What types of cannabis products does OrganiGram offer?
Where is OrganiGram Holdings Inc. based?
How can I contact OrganiGram's client services team?
Is OrganiGram involved in research and development?
What regulations does OrganiGram operate under?
Is OrganiGram Holdings Inc. publicly traded?
Where can I find more information about OrganiGram?
What makes OrganiGram's cannabis products unique?